Cargando…
The Mechanisms of HBV-Induced Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a common malignancy, and the hepatitis B virus (HBV) is its major pathogenic factor. Over the past decades, it has been confirmed that HBV infection could promote disease progression through a variety of mechanisms, ultimately leading to the malignant transformation...
Autores principales: | Jiang, Yu, Han, Qiuju, Zhao, Huajun, Zhang, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147889/ https://www.ncbi.nlm.nih.gov/pubmed/34046368 http://dx.doi.org/10.2147/JHC.S307962 |
Ejemplares similares
-
Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis
por: Jiang, Yu, et al.
Publicado: (2021) -
Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular Carcinoma
por: Li, Ya, et al.
Publicado: (2020) -
CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
por: Zhao, Huajun, et al.
Publicado: (2022) -
Targeted inhibition of STAT3 induces immunogenic cell death of hepatocellular carcinoma cells via glycolysis
por: Li, Ya, et al.
Publicado: (2022) -
Chitosan Nanovaccines as Efficient Carrier Adjuvant System for IL-12 with Enhanced Protection Against HBV
por: Zhao, Huajun, et al.
Publicado: (2021)